Cargando…
COVID-19 Brand Switching: Expectation on Protective Efficacy
Autores principales: | Joob, Beuy, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284245/ https://www.ncbi.nlm.nih.gov/pubmed/37351033 http://dx.doi.org/10.4103/ijpvm.ijpvm_47_21 |
Ejemplares similares
-
Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19
por: Joob, Beuy, et al.
Publicado: (2021) -
Expected efficacy of HPV vaccine in prevention of cervix cancer in Thailand
por: Joob, Beuy, et al.
Publicado: (2014) -
Cytokine Receptor Allele Frequency, Immunogenicity, and Efficacy of New COVID-19 Vaccine in Different Setting
por: Joob, Beuy, et al.
Publicado: (2023) -
New COVID-19 Variant, VUI-202012/01: Molecular Change, Epitope Alteration, and Implication for Vaccine Efficacy
por: Joob, Beuy, et al.
Publicado: (2021) -
COVID-19 Pandemic and Ophthalmologists
por: Beuy, Joob, et al.
Publicado: (2020)